CIK 0001682852 · Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813467528
- Phone
- 6177146500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,875,818
- in 4 filings, $33.9M under 10b5-1 plans
Net −$33,875,818. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-27 | Mock James M Chief Financial Officer | Option exercise | +9,901 | 55,693 | ||
| 2026-02-27 | Mock James M Chief Financial Officer | Shares withheld for taxes | −4,788 | $51.71 | $248K | 50,905 |
| 2026-02-27 | Mock James M Chief Financial Officer | Option exercise · Restricted Stock Units | −329 | 1,315 | ||
| 2026-02-27 | Mock James M Chief Financial Officer | Option exercise · Restricted Stock Units | −774 | 6,189 | ||
| 2026-02-27 | Mock James M Chief Financial Officer | Option exercise · Restricted Stock Units | −9,901 | 29,705 | ||
| 2026-02-23 | Hoge Stephen President | Option exercise 10b5-1 | +111,679 | $19.15 | $2.1M | 1,569,106 |
| 2026-02-23 | Hoge Stephen President | Option exercise 10b5-1 | +48,330 | $19.15 | $926K | 1,617,436 |
| 2026-02-23 | Hoge Stephen President | Sale 10b5-1 | −160,009 | $48.84 | $7.8M | 1,457,427 |
| 2026-02-23 | Hoge Stephen President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −111,679 | 111,678 | ||
| 2026-02-23 | Hoge Stephen President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −48,330 | 48,330 | ||
| 2026-02-11 | Mock James M Chief Financial Officer | Grant or award | +2,630 | 46,502 | ||
| 2026-02-11 | Mock James M Chief Financial Officer | Shares withheld for taxes | −1,278 | $41.99 | $54K | 45,224 |
| 2026-02-11 | Klinger Shannon Thyme Chief Legal Officer | Grant or award | +2,630 | 55,861 | ||
| 2026-02-11 | Klinger Shannon Thyme Chief Legal Officer | Shares withheld for taxes | −1,334 | $41.99 | $56K | 54,527 |
| 2026-02-11 | Hoge Stephen President | Grant or award | +4,884 | 1,459,789 | ||
| 2026-02-11 | Hoge Stephen President | Shares withheld for taxes | −2,362 | $41.99 | $99K | 1,457,427 |
| 2026-02-11 | Bancel Stephane Chief Executive Officer | Grant or award | +11,271 | 6,193,241 | ||
| 2026-02-11 | Bancel Stephane Chief Executive Officer | Shares withheld for taxes | −5,450 | $41.99 | $229K | 6,187,791 |
| 2026-01-05 | Mock James M Chief Financial Officer | Option exercise | +1,452 | 44,652 | ||
| 2026-01-05 | Mock James M Chief Financial Officer | Shares withheld for taxes | −780 | $30.86 | $24K | 43,872 |
Page 11 of 20 · 389 trades